ConductScience.org, home

Paper20145155

Transcriptional profiles of CD133+ and CD133- glioblastoma-derived cancer stem cell lines suggest different cells of origin.

Lottaz C and 12 others. Cancer Res, 2010. Cited by 211 papers, by iCite.

Cite this record

ConductScience Library. Transcriptional profiles of CD133+ and CD133- glioblastoma-derived cancer stem cell lines suggest different cells of origin. Papers, record 20145155. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20145155

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Transcriptional profiles of CD133+ and CD133- glioblastoma-derived cancer stem cell lines suggest different cells of origin.
PubMed
Journal
Cancer Res
PubMed
Year
2010
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
211
iCite
Relative citation ratio, by iCite
4.67
iCite
Revised in PubMed
2022-08-25
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lottaz CClaudio
2Beier DDagmar
3Meyer KKatharina
4Kumar PPraveen
5Hermann AAndreas
6Schwarz JJohannes
7Junker MMarkus
8Oefner PJPeter J
9Bogdahn UUlrich
10Wischhusen JJörg
11Spang RRainer
12Storch AAlexander
13Beier CPChristoph P

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, CDMajor topic
GlioblastomaMajor topic
GlycoproteinsMajor topic
Neoplastic Stem CellsMajor topic
AC133 Antigen
Cell Growth Processes
Cell Line, Tumor
Gene Expression Profiling
Humans
Mesoderm
Peptides
Transcription, Genetic

Source PubMed

Download CSV of topics

Cited by146

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 211 citations.

PMIDTitleJournalYearIn PapersSource
41883713Targeted attack: Harnessing myelin-specific plasmolipin for suppression of neuroblastoma and glioblastoma.Mol Ther Oncol2026https://conductscience.org/library/papers/41883713PubMed
40898306Phenotypic variations in glioma stem cells: regulatory mechanisms and implications for therapeutic strategies.J Transl Med2025https://conductscience.org/library/papers/40898306PubMed
40616096The reprogramming impact of SMAC-mimetic on glioblastoma stem cells and the immune tumor microenvironment evolution.J Exp Clin Cancer Res2025https://conductscience.org/library/papers/40616096PubMed
40106404Identification of distinct profiles of glioblastoma through the immunocapture of extracellular vesicles from patient plasma.PLoS One2025https://conductscience.org/library/papers/40106404PubMed
39990669Breaking Immunosuppression to Enhance Cancer Stem Cell-Targeted Immunotherapy.Int J Biol Sci2025https://conductscience.org/library/papers/39990669PubMed
39936970Glycosylated Delphinidins Decrease Chemoresistance to Temozolomide by Regulating NF-κB/MGMT Signaling in Glioblastoma.Cells2025https://conductscience.org/library/papers/39936970PubMed
39755992Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in breast cancer.Discov Oncol2025https://conductscience.org/library/papers/39755992PubMed
39137729Interleukin-21 engineering enhances NK cell activity against glioblastoma via CEBPD.Cancer Cell2024https://conductscience.org/library/papers/39137729PubMed
38965243Cancer stem cells: advances in knowledge and implications for cancer therapy.Signal Transduct Target Ther2024https://conductscience.org/library/papers/38965243PubMed
38926605Stemness subtypes in lower-grade glioma with prognostic biomarkers, tumor microenvironment, and treatment response.Sci Rep2024https://conductscience.org/library/papers/38926605PubMed
38869884Metabolic profiling of glioblastoma stem cells reveals pyruvate carboxylase as a critical survival factor and potential therapeutic target.Neuro Oncol2024https://conductscience.org/library/papers/38869884PubMed
38712813Comprehensive understanding of glioblastoma molecular phenotypes: classification, characteristics, and transition.Cancer Biol Med2024https://conductscience.org/library/papers/38712813PubMed
38201528Progress in Glioma Stem Cell Research.Cancers (Basel)2023https://conductscience.org/library/papers/38201528PubMed
38090567Cancer stem cell-immune cell crosstalk in breast tumor microenvironment: a determinant of therapeutic facet.Front Immunol2023https://conductscience.org/library/papers/38090567PubMed
37958764Cellular Effects of Selected Unsymmetrical Bisacridines on the Multicellular Tumor Spheroids of HCT116 Colon and A549 Lung Cancer Cells in Comparison to Monolayer Cultures.Int J Mol Sci2023https://conductscience.org/library/papers/37958764PubMed
37460561Multiplexed RNA profiling by regenerative catalysis enables blood-based subtyping of brain tumors.Nat Commun2023https://conductscience.org/library/papers/37460561PubMed
36522586Aggressive migration in acidic pH of a glioblastoma cancer stem cell line in vitro is independent of ASIC and KCa3.1 ion channels, but involves phosphoinositide 3-kinase.Pflugers Arch2023https://conductscience.org/library/papers/36522586PubMed
36338705Heterogeneity of glioblastoma stem cells in the context of the immune microenvironment and geospatial organization.Front Oncol2022https://conductscience.org/library/papers/36338705PubMed
35798319The Interaction between DNMT1 and High-Mannose CD133 Maintains the Slow-Cycling State and Tumorigenic Potential of Glioma Stem Cell.Adv Sci (Weinh)2022https://conductscience.org/library/papers/35798319PubMed
35721833Meta-analysis on reporting practices as a source of heterogeneity in in vitro cancer research.BMJ Open Sci2022https://conductscience.org/library/papers/35721833PubMed

See all 146 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BMP1649PubTator's text mininghttps://conductscience.org/library/genes/649NCBI Gene
PROM18842PubTator's text mininghttps://conductscience.org/library/genes/8842NCBI Gene
TGFB17040PubTator's text mininghttps://conductscience.org/library/genes/7040NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20145155

GET https://conductscience.org/api/papers/v1/20145155/cited_by?page=2